Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Defibrillators, Implantable | 17 | 2016 | 329 | 1.170 |
Why?
|
| Pacemaker, Artificial | 15 | 2013 | 157 | 0.580 |
Why?
|
| Electric Countershock | 8 | 2010 | 130 | 0.440 |
Why?
|
| Ventricular Fibrillation | 5 | 2007 | 85 | 0.380 |
Why?
|
| Cardiac Pacing, Artificial | 7 | 2010 | 174 | 0.380 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2008 | 141 | 0.310 |
Why?
|
| Cardiac Resynchronization Therapy | 3 | 2016 | 119 | 0.310 |
Why?
|
| Hemodynamics | 5 | 2014 | 705 | 0.300 |
Why?
|
| Atrial Fibrillation | 5 | 2009 | 248 | 0.280 |
Why?
|
| Heart Failure | 6 | 2016 | 1179 | 0.280 |
Why?
|
| Arrhythmias, Cardiac | 5 | 2009 | 239 | 0.260 |
Why?
|
| Bundle-Branch Block | 4 | 2010 | 50 | 0.230 |
Why?
|
| Heart Rate | 9 | 2014 | 568 | 0.220 |
Why?
|
| Differential Threshold | 3 | 2010 | 27 | 0.210 |
Why?
|
| Renal Dialysis | 2 | 2001 | 174 | 0.210 |
Why?
|
| Clinical Trials as Topic | 2 | 2005 | 848 | 0.200 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2010 | 277 | 0.200 |
Why?
|
| Aged | 28 | 2016 | 14842 | 0.180 |
Why?
|
| Tilt-Table Test | 1 | 1999 | 1 | 0.180 |
Why?
|
| Electrocardiography | 5 | 2007 | 601 | 0.170 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2010 | 116 | 0.170 |
Why?
|
| Amiodarone | 2 | 1990 | 21 | 0.170 |
Why?
|
| Heart Block | 5 | 1991 | 49 | 0.170 |
Why?
|
| Heart Atria | 3 | 2009 | 206 | 0.170 |
Why?
|
| Middle Aged | 31 | 2016 | 21119 | 0.160 |
Why?
|
| Myocardial Ischemia | 1 | 1999 | 172 | 0.160 |
Why?
|
| Stroke Volume | 3 | 1989 | 586 | 0.150 |
Why?
|
| Humans | 53 | 2016 | 68525 | 0.150 |
Why?
|
| Male | 39 | 2016 | 37281 | 0.140 |
Why?
|
| Coronary Disease | 3 | 1999 | 358 | 0.140 |
Why?
|
| Equipment Failure | 5 | 1994 | 112 | 0.140 |
Why?
|
| Female | 35 | 2016 | 38015 | 0.140 |
Why?
|
| Treatment Outcome | 11 | 2016 | 7028 | 0.130 |
Why?
|
| Coronary Artery Disease | 1 | 2001 | 696 | 0.130 |
Why?
|
| Tachycardia | 2 | 2003 | 53 | 0.130 |
Why?
|
| Automobile Driving | 3 | 2005 | 88 | 0.120 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2016 | 161 | 0.120 |
Why?
|
| Patients | 1 | 1994 | 69 | 0.120 |
Why?
|
| Heart Ventricles | 4 | 2010 | 738 | 0.110 |
Why?
|
| Monitoring, Intraoperative | 1 | 1993 | 53 | 0.110 |
Why?
|
| beta-Alanine | 1 | 2013 | 20 | 0.110 |
Why?
|
| Antithrombins | 1 | 2013 | 32 | 0.110 |
Why?
|
| Tachycardia, Ventricular | 2 | 2005 | 153 | 0.110 |
Why?
|
| Heart Valve Prosthesis | 2 | 1991 | 222 | 0.100 |
Why?
|
| Benzimidazoles | 1 | 2013 | 128 | 0.100 |
Why?
|
| Endocarditis, Subacute Bacterial | 1 | 1991 | 1 | 0.100 |
Why?
|
| Gastroscopy | 1 | 1991 | 45 | 0.100 |
Why?
|
| Sick Sinus Syndrome | 4 | 1991 | 18 | 0.100 |
Why?
|
| Caregivers | 1 | 1994 | 365 | 0.100 |
Why?
|
| Electroencephalography | 1 | 1993 | 418 | 0.100 |
Why?
|
| Kidney Failure, Chronic | 2 | 2001 | 365 | 0.090 |
Why?
|
| Ventricular Function, Left | 1 | 2014 | 481 | 0.090 |
Why?
|
| Lidocaine | 1 | 1990 | 36 | 0.090 |
Why?
|
| Digoxin | 2 | 1988 | 24 | 0.090 |
Why?
|
| Prospective Studies | 8 | 2013 | 3702 | 0.090 |
Why?
|
| Angioplasty, Balloon, Coronary | 2 | 2001 | 178 | 0.090 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 1989 | 16 | 0.090 |
Why?
|
| Atrial Function | 1 | 2009 | 8 | 0.090 |
Why?
|
| Phenethylamines | 1 | 2009 | 20 | 0.090 |
Why?
|
| Ventricular Dysfunction | 1 | 2009 | 15 | 0.090 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2009 | 100 | 0.080 |
Why?
|
| Heart Septum | 1 | 2008 | 84 | 0.080 |
Why?
|
| Patient Education as Topic | 2 | 2009 | 424 | 0.080 |
Why?
|
| Primary Prevention | 2 | 2008 | 115 | 0.080 |
Why?
|
| Thrombosis | 1 | 2009 | 218 | 0.080 |
Why?
|
| Medical Audit | 1 | 1988 | 44 | 0.080 |
Why?
|
| Aged, 80 and over | 6 | 2009 | 4843 | 0.080 |
Why?
|
| Sulfonamides | 1 | 2009 | 141 | 0.080 |
Why?
|
| Vena Cava, Superior | 1 | 2007 | 41 | 0.080 |
Why?
|
| Aortic Valve Insufficiency | 1 | 1987 | 47 | 0.080 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 2 | 2009 | 61 | 0.080 |
Why?
|
| Monitoring, Physiologic | 2 | 1988 | 219 | 0.080 |
Why?
|
| Aortic Valve Stenosis | 1 | 1989 | 177 | 0.070 |
Why?
|
| Benzofurans | 1 | 1986 | 21 | 0.070 |
Why?
|
| Survival Rate | 4 | 2016 | 1055 | 0.070 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2007 | 57 | 0.070 |
Why?
|
| Data Collection | 1 | 1988 | 420 | 0.070 |
Why?
|
| Patient Satisfaction | 1 | 2009 | 378 | 0.070 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 1986 | 106 | 0.070 |
Why?
|
| Stents | 2 | 2001 | 657 | 0.070 |
Why?
|
| Risk Factors | 4 | 2016 | 5719 | 0.070 |
Why?
|
| Time Factors | 8 | 2014 | 4655 | 0.070 |
Why?
|
| Syncope | 1 | 2005 | 23 | 0.070 |
Why?
|
| Follow-Up Studies | 6 | 2008 | 3256 | 0.070 |
Why?
|
| Atrioventricular Node | 1 | 1985 | 39 | 0.070 |
Why?
|
| Equipment Design | 5 | 2003 | 500 | 0.060 |
Why?
|
| Diffusion of Innovation | 1 | 2005 | 102 | 0.060 |
Why?
|
| Adult | 14 | 2009 | 21375 | 0.060 |
Why?
|
| Heart Conduction System | 1 | 1985 | 119 | 0.060 |
Why?
|
| Information Dissemination | 1 | 2005 | 113 | 0.060 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2003 | 34 | 0.060 |
Why?
|
| Streptokinase | 1 | 1983 | 23 | 0.060 |
Why?
|
| Public Health | 1 | 2005 | 201 | 0.060 |
Why?
|
| Health Policy | 1 | 2005 | 221 | 0.060 |
Why?
|
| United States | 5 | 2016 | 7335 | 0.050 |
Why?
|
| Retrospective Studies | 5 | 2016 | 7264 | 0.050 |
Why?
|
| Patient Compliance | 1 | 2005 | 402 | 0.050 |
Why?
|
| Ethanol | 1 | 2008 | 892 | 0.050 |
Why?
|
| Time | 1 | 2001 | 57 | 0.050 |
Why?
|
| Myocardial Contraction | 3 | 1989 | 383 | 0.050 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 1981 | 34 | 0.050 |
Why?
|
| Cardiac Catheterization | 3 | 1991 | 419 | 0.050 |
Why?
|
| Combined Modality Therapy | 3 | 2009 | 951 | 0.050 |
Why?
|
| South Carolina | 3 | 2001 | 2750 | 0.050 |
Why?
|
| Comorbidity | 2 | 2016 | 1425 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2001 | 714 | 0.050 |
Why?
|
| Syncope, Vasovagal | 1 | 1999 | 5 | 0.040 |
Why?
|
| Ventricular Premature Complexes | 1 | 1999 | 10 | 0.040 |
Why?
|
| Isoproterenol | 1 | 1999 | 163 | 0.040 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1999 | 92 | 0.040 |
Why?
|
| Electrodes, Implanted | 2 | 1990 | 98 | 0.040 |
Why?
|
| Heart Diseases | 1 | 1981 | 276 | 0.040 |
Why?
|
| Cardiac Output | 2 | 1991 | 133 | 0.040 |
Why?
|
| Exercise Test | 3 | 1989 | 242 | 0.040 |
Why?
|
| Myocardial Infarction | 1 | 1983 | 807 | 0.040 |
Why?
|
| Diltiazem | 2 | 1987 | 25 | 0.040 |
Why?
|
| Ethics | 1 | 1997 | 17 | 0.040 |
Why?
|
| Angina Pectoris | 2 | 1987 | 61 | 0.040 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2009 | 97 | 0.040 |
Why?
|
| Causality | 1 | 2016 | 81 | 0.040 |
Why?
|
| Exercise | 2 | 1992 | 657 | 0.030 |
Why?
|
| Anticoagulants | 2 | 2009 | 356 | 0.030 |
Why?
|
| Equipment Safety | 1 | 1994 | 50 | 0.030 |
Why?
|
| Incidence | 2 | 2016 | 1582 | 0.030 |
Why?
|
| Dabigatran | 1 | 2013 | 35 | 0.030 |
Why?
|
| Fear | 1 | 1994 | 239 | 0.030 |
Why?
|
| Proportional Hazards Models | 2 | 2005 | 791 | 0.030 |
Why?
|
| Hypotension | 1 | 1993 | 74 | 0.030 |
Why?
|
| Intraoperative Complications | 1 | 1993 | 129 | 0.030 |
Why?
|
| Ceftriaxone | 1 | 1991 | 32 | 0.020 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 1991 | 25 | 0.020 |
Why?
|
| Echocardiography | 2 | 1991 | 515 | 0.020 |
Why?
|
| Anxiety | 1 | 1994 | 422 | 0.020 |
Why?
|
| Gram-Negative Bacteria | 1 | 1991 | 55 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2007 | 1753 | 0.020 |
Why?
|
| Lipoproteins, LDL | 1 | 1993 | 343 | 0.020 |
Why?
|
| Autoantibodies | 1 | 1993 | 434 | 0.020 |
Why?
|
| Biomedical Engineering | 1 | 1990 | 20 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2016 | 2356 | 0.020 |
Why?
|
| Magnetics | 1 | 1990 | 52 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2010 | 260 | 0.020 |
Why?
|
| Rest | 1 | 1989 | 78 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2007 | 2077 | 0.020 |
Why?
|
| Rhode Island | 1 | 2009 | 9 | 0.020 |
Why?
|
| Aortic Valve | 1 | 1991 | 249 | 0.020 |
Why?
|
| Injections, Intralesional | 1 | 2008 | 25 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 1990 | 567 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2009 | 272 | 0.020 |
Why?
|
| Probability | 1 | 2008 | 244 | 0.020 |
Why?
|
| Concurrent Review | 1 | 1988 | 2 | 0.020 |
Why?
|
| Quality of Life | 1 | 1997 | 1515 | 0.020 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1988 | 14 | 0.020 |
Why?
|
| Age Distribution | 1 | 2009 | 319 | 0.020 |
Why?
|
| Benzothiadiazines | 1 | 1987 | 4 | 0.020 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 1987 | 8 | 0.020 |
Why?
|
| Educational Status | 1 | 2009 | 273 | 0.020 |
Why?
|
| Cardiomegaly | 1 | 1989 | 213 | 0.020 |
Why?
|
| Heart | 2 | 1990 | 850 | 0.020 |
Why?
|
| Heart Aneurysm | 1 | 1987 | 21 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2008 | 536 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 1993 | 665 | 0.020 |
Why?
|
| Operating Rooms | 1 | 1988 | 108 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 306 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1987 | 189 | 0.020 |
Why?
|
| Bioprosthesis | 1 | 1987 | 101 | 0.020 |
Why?
|
| Surgical Wound Infection | 1 | 1988 | 168 | 0.020 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2007 | 75 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2007 | 546 | 0.020 |
Why?
|
| Catheter Ablation | 1 | 2008 | 229 | 0.020 |
Why?
|
| Verapamil | 1 | 1986 | 30 | 0.020 |
Why?
|
| Nifedipine | 1 | 1986 | 40 | 0.020 |
Why?
|
| Aging | 1 | 1992 | 911 | 0.020 |
Why?
|
| Medicare | 1 | 1988 | 316 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2007 | 765 | 0.020 |
Why?
|
| Benzazepines | 1 | 1986 | 104 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 1985 | 166 | 0.020 |
Why?
|
| Prevalence | 1 | 2009 | 1609 | 0.020 |
Why?
|
| Triamcinolone | 1 | 1984 | 11 | 0.020 |
Why?
|
| Atmospheric Pressure | 1 | 1983 | 8 | 0.010 |
Why?
|
| Equipment Failure Analysis | 1 | 2003 | 121 | 0.010 |
Why?
|
| Safety | 1 | 2003 | 145 | 0.010 |
Why?
|
| Prognosis | 1 | 1987 | 2093 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2008 | 2004 | 0.010 |
Why?
|
| Eisenmenger Complex | 1 | 1981 | 4 | 0.010 |
Why?
|
| Abortion, Therapeutic | 1 | 1981 | 5 | 0.010 |
Why?
|
| Mitral Valve Stenosis | 1 | 1981 | 15 | 0.010 |
Why?
|
| Furosemide | 1 | 1981 | 45 | 0.010 |
Why?
|
| Penicillins | 1 | 1981 | 32 | 0.010 |
Why?
|
| Mitral Valve Prolapse | 1 | 1981 | 40 | 0.010 |
Why?
|
| Aminoglycosides | 1 | 1981 | 54 | 0.010 |
Why?
|
| Pain | 1 | 1984 | 472 | 0.010 |
Why?
|
| Recurrence | 1 | 1983 | 948 | 0.010 |
Why?
|
| Hypertension | 1 | 1987 | 1531 | 0.010 |
Why?
|
| Child | 1 | 1989 | 6400 | 0.010 |
Why?
|
| Algorithms | 1 | 2003 | 1194 | 0.010 |
Why?
|
| Freedom | 1 | 1997 | 9 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 1983 | 866 | 0.010 |
Why?
|
| Ontario | 1 | 1997 | 24 | 0.010 |
Why?
|
| Myocardium | 1 | 1983 | 1204 | 0.010 |
Why?
|
| Accidents, Traffic | 1 | 1997 | 109 | 0.010 |
Why?
|
| Pregnancy | 1 | 1981 | 2331 | 0.010 |
Why?
|
| Drug Therapy, Combination | 2 | 1987 | 648 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 1997 | 384 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1993 | 196 | 0.010 |
Why?
|
| Reference Values | 1 | 1993 | 579 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1993 | 567 | 0.010 |
Why?
|
| Echocardiography, Doppler | 1 | 1991 | 87 | 0.010 |
Why?
|
| Surgical Instruments | 1 | 1990 | 44 | 0.010 |
Why?
|
| Foreign Bodies | 1 | 1990 | 58 | 0.010 |
Why?
|
| Office Visits | 1 | 1988 | 83 | 0.000 |
Why?
|
| Telephone | 1 | 1988 | 160 | 0.000 |
Why?
|
| Propranolol | 1 | 1987 | 102 | 0.000 |
Why?
|
| Delayed-Action Preparations | 1 | 1987 | 120 | 0.000 |
Why?
|
| Diuretics | 1 | 1987 | 96 | 0.000 |
Why?
|
| Mitral Valve | 1 | 1987 | 166 | 0.000 |
Why?
|
| Costs and Cost Analysis | 1 | 1986 | 193 | 0.000 |
Why?
|
| Contracture | 1 | 1984 | 15 | 0.000 |
Why?
|
| Dogs | 1 | 1983 | 490 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1986 | 1745 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1987 | 1447 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1984 | 1329 | 0.000 |
Why?
|
| Animals | 1 | 1983 | 20877 | 0.000 |
Why?
|